About CranioVation
CranioVation is a company based in Rochester (United States) founded in 2017 was acquired by Springfield in May 2018. CranioVation has raised $7.61 million across 6 funding rounds from investors including Springfield Properties. CranioVation operates in a competitive market with competitors including PhotoPharmics, Lumeda, Adgero Biopharma, SpectraCure and Photolitec, among others.
- Headquarter Rochester, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.61 M (USD)
in 6 rounds
-
Latest Funding Round
$6 M (USD), Series A
Dec 23, 2020
- Investors
-
Employee Count
Not available
-
Acquired by
Springfield
(May 02, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CranioVation
Unlock access to complete
Unlock access to complete
Funding Insights of CranioVation
CranioVation has successfully raised a total of $7.61M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CranioVation
CranioVation has secured backing from 1 investor. Prominent investors backing the company include Springfield Properties.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Springfield Properties is engaged in building new homes in Scotland.
|
Locked | Locked | Locked |
Investor details for CranioVation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CranioVation
Investment portfolio details for CranioVation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CranioVation
Detailed financials for CranioVation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Craniovation Comparisons
Peer comparison for CranioVation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CranioVation
CranioVation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Lumeda, Adgero Biopharma, SpectraCure and Photolitec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Photodynamic therapy device for lung cancer treatment is developed.
|
|
| Locked | Locked | Locked |
Photodynamic therapy for cutaneous metastatic breast cancer is developed.
|
|
| Locked | Locked | Locked |
Developer of Interstitial photo dynamic therapy for solid tumours
|
|
| Locked | Locked | Locked |
Supplies photosensitizing compounds for tumor imaging and photodynamic cancer therapy.
|
Detailed competitors of CranioVation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Craniovation
Complete news archive for CranioVation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CranioVation
CranioVation was founded in 2017.
CranioVation is headquartered in Rochester, United States.
CranioVation is a funded company, having raised a total of $7.61M across 6 funding rounds to date.
CranioVation was founded in 2017 and is located in Rochester, United States. Devices for the minimally invasive treatment of brain tumors are supplied by the company within the medical devices sector. Photodynamic therapy is employed, where light activates photosensitizers to target and eliminate cancer cells. Deeply located tumors can be addressed through brief procedures, typically a few minutes long, conducted while patients are awake. Operations emphasize neuro-oncological applications.
CranioVation's top competitors include PhotoPharmics, ImPact Biotech and Adgero Biopharma.
CranioVation has 1 investor. Key investors include Springfield Properties.